PATENT CLAIM ANALYSIS

Application Number: 15964604
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "314000"]

Abstract:
Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.

Claim (Index 12):
The method or therapeutic combination of any of the  claims 7 - 11 , wherein the second pharmaceutically acceptable formulation is injected directly into a tumor.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15500618', '13817214', '15822556', '15195723', '14256521']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7175883727116192
- 35 USC 102 Novelty (BERT): 0.6594396113005287
- Combined Prediction Score: 0.7117734965705101
- Mean Citation Score: 387.959494
- Max Citation Score: 736.13446
- Similarity Product: 573.3316688324319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test